---
category: news
title: "AION Labs launches AI startup to improve drug trials"
excerpt: "AION Labs has formed OMEC.AI, the labâ€™s first startup approved by the Israel Innovation Authority. The new company will develop AI-powered solutions to analyze pre-clinical data and identify gaps in efficacy and safety to improve the probability of success of drug candidates in clinical trials."
publishedDateTime: 2022-09-28T19:57:00Z
originalUrl: "https://www.labiotech.eu/trends-news/aion-labs-launches-ai-startup-improve-drug-trials/"
webUrl: "https://www.labiotech.eu/trends-news/aion-labs-launches-ai-startup-improve-drug-trials/"
type: article
quality: 37
heat: -1
published: false

provider:
  name: labiotech
  domain: labiotech.eu

topics:
  - AI

images:
  - url: "https://www.labiotech.eu/wp-content/uploads/2022/06/shutterstock-artificial-intelligence-.jpg"
    width: 1024
    height: 683
    isCached: true

related:
  - title: "Israeli innovation lab backed by pharmaceutical, biotech giants mints 1st AI startup"
    excerpt: "AION Labs, a Rehovot-based consortium formed by Pfizer, Merck, AstraZeneca, Teva and others, sets up company that will help drug firms improve chances of success in clinical trials"
    publishedDateTime: 2022-09-28T11:13:00Z
    webUrl: "https://www.timesofisrael.com/israeli-innovation-lab-backed-by-pharmaceutical-biotech-giants-mints-1st-ai-startup/"
    ampWebUrl: "https://www.timesofisrael.com/israeli-innovation-lab-backed-by-pharmaceutical-biotech-giants-mints-1st-ai-startup/amp/"
    cdnAmpWebUrl: "https://www-timesofisrael-com.cdn.ampproject.org/c/s/www.timesofisrael.com/israeli-innovation-lab-backed-by-pharmaceutical-biotech-giants-mints-1st-ai-startup/amp/"
    type: article
    provider:
      name: The Times of Israel
      domain: timesofisrael.com
    quality: 50
    images:
      - url: "https://static.timesofisrael.com/www/uploads/2022/09/Aion-_-Portraits-_-by-Elad-Malka-4509-640x400.jpg"
        width: 640
        height: 400
        isCached: true

secured: "jrkh/CjXnMAipp3NMqAlbmAn9O69weeMSGpZIqRosAJXgEn7DiEpKMw2jSLB50sNbtpCzMWEg421WvyPyh7+mwn0yRLo+/qrdsqa95Vjoe8JtAqO9FeC2S35+AVzoHEtKyrAyE3/VXld9xtwOvE1R1v5Nf+KIFZ8nzym9M0PN21q7/YeiwyYir0mtv/QQ112bU6KcM2dE4ii2ekPIMPLc3aGJ0LEHzLWzp6U7y/ok/+3oMkgKo+Rnvpnt2MZqPEGP6OokDTFf2zb1S5DAim3CG51ekejRoW7nDsml05eLUelh0ubhFgzCxAg/TBSHQ8Y47fdo4UR2+ywmV2o7dKiGLFBVN2Kb+9bxMwj+HY7UbaGtCIEbkq2vw9fiGsz4wwCsVn87sprZTXEZ/6W339SUBSicEj87PQwqKCw1e7/ct08/x+41jy/qkkUGHj/klvxEZDVa1sM+SSRLh6Wz2OHbmTqNHaKzIPFXljxUGOLW2LjViwzHU5gbfuUmxYKtWIB/20k5qk2cdGwIHP0QLSHLQ==;KBF919aXvkWHrkmvmK3qNQ=="
---

